BUZZ-AstraZeneca: Q4 earnings underwhelm

** AstraZeneca down 2.7 pct around 1-mth lows after Q4 results come in shy of expectations ** Q4 sales fell 2 pct to $6.68 bln vs analysts' forecast of $6.79 bln; core EPS, however, expected to increase ...